Primary Hpv Cervical Cancer Screening In The United States: Are We Ready?

Keywords

cervical cancer; primary HPV screening; USPSTF guidelines

Abstract

In September 2017, the United States Preventive Services Task Force put forth updated draft guidelines for cervical cancer screening in the United States, which were then open to public comment. The recommendations allowed for every-3-year cervical cytology screening in women aged 21 to 65 years with an option for every-5-year high-risk human papillomavirus testing in women aged 30 to 65 years. There was no option for cotesting. Other recommendations were similar to those published by other professional organizations. The Cytopathology Education and Technology Consortium provided an official response during the open comment period, which is summarized here along with additional commentary by the authors.

Publication Date

1-1-2018

Publication Title

Journal of the American Society of Cytopathology

Volume

7

Issue

1

Number of Pages

50-55

Document Type

Article

Personal Identifier

scopus

DOI Link

https://doi.org/10.1016/j.jasc.2017.12.001

Socpus ID

85039037437 (Scopus)

Source API URL

https://api.elsevier.com/content/abstract/scopus_id/85039037437

This document is currently not available here.

Share

COinS